Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- LS-B2003 - Provider product page
- Provider
- LSBio
- Product name
- PathPlus™ KRT19 / CK19 / Cytokeratin 19 Antibody (clone A53-B/A2) LS-B2003
- Antibody type
- Monoclonal
- Description
- Affinity purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- A53-B/A2
- Storage
- Store at 4°C. Store undiluted.
No comments: Submit comment
Enhanced validation
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- MCF-7 cell extract was resolved by electrophoresis, transferred to nitrocellulose and probed with monoclonal anti-cytokeratin 19 antibody (clone A53-B/A2). Proteins were visualized using a goat anti-mouse secondary conjugated to HRP and a chemiluminescence detection system.
Supportive validation
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- MCF-7 cells were stained with anti-Cytokeratin 19 (clone A53-B/A2), followed by Alexa Fluor 546 secondary antibody and DAPI (nuclei). Images were acquired on a Nikon FC300 inverted microscope at 20X magnification. Data provided by Dr. John Nolan, La Jolla Bioengineering Institute.
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- MCF-7 cells were stained with anti-Cytokeratin 19 (clone A53-B/A2), followed by Alexa Fluor 546 secondary antibody and DAPI (nuclei). Images were acquired on a Nikon FC300 inverted microscope at 20X magnification. Data provided by Dr. John Nolan, La Jolla Bioengineering Institute.
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- MCF-7 cells were stained with anti-Cytokeratin 19 (clone A53-B/A2), followed by Alexa Fluor 546 secondary antibody and DAPI (nuclei). Images were acquired on a Nikon FC300 inverted microscope at 20X magnification. Data provided by Dr. John Nolan, La Jolla Bioengineering Institute.